TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Non Operating Income (2022 - 2026)

Updated

TScan Therapeutics' Non Operating Income was -$54,000 in Q3 2026, compared with $1.34 million a year earlier.

Analysis

TScan Therapeutics (TCRX) Non Operating Income (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, TScan Therapeutics' Non Operating Income was $1.43 million through Sep 30, 2026, down 76.4% year-over-year; for FY2025, it was $6.05 million, down 17.4% from FY2024.

  • Non Operating Income shows a four-year compound annual growth rate of 340.9% (FY2021 to FY2025).
  • In earlier years, Non Operating Income was $7.32 million in FY2024 (+72.7%), $4.24 million in FY2023 (+921.7%), $415,000 in FY2022 and $16,000 in FY2021.
  • The Q3 2026 figure marks the lowest quarterly Non Operating Income since Q4 2022.
  • Compared with a year earlier, Non Operating Income was higher in 1 of the last seven quarters, with an average decline of 32.8%.
  • The best year-over-year quarter for Non Operating Income over five years was Q1 2024 (growth of 583.9%); the worst was Q2 2026 (a decline of 92.1%).
  • Per Business Quant data, TCRX's Non Operating Income in the three quarters before Q3 2026 was $134,000 (Q2 2026), $473,000 (Q1 2026) and $881,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -15,526.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -202.00 Mn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -130.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -54,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -54,000.00
Jun 30, 2026 134,000.00
Mar 31, 2026 473,000.00
Dec 31, 2025 881,000.00
Sep 30, 2025 1.34 Mn
Jun 30, 2025 1.70 Mn
Mar 31, 2025 2.12 Mn
Dec 31, 2024 903,000.00
Sep 30, 2024 2.74 Mn
Jun 30, 2024 2.45 Mn
Mar 31, 2024 1.23 Mn
Dec 31, 2023 1.74 Mn
Sep 30, 2023 1.75 Mn
Jun 30, 2023 565,000.00
Mar 31, 2023 180,000.00
Dec 31, 2022 -74,000.00
Sep 30, 2022 333,000.00
Jun 30, 2022 149,000.00
Mar 31, 2022 7,000.00
API Access

TScan Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=TCRX&period=max&api_key=YOUR_API_KEY